HEADER TRANSPORT PROTEIN 09-MAY-11 3RWX TITLE CRYSTAL STRUCTURE OF A PUTATIVE OUTER MEMBRANE PROTEIN (BF2706) FROM TITLE 2 BACTEROIDES FRAGILIS NCTC 9343 AT 2.40 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYPOTHETICAL BACTERIAL OUTER MEMBRANE PROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PUTATIVE LIPOPROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACTEROIDES FRAGILIS; SOURCE 3 ORGANISM_TAXID: 272559; SOURCE 4 STRAIN: NCTC 9343; SOURCE 5 GENE: BF2706; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS TRANSMEMBRANE BETA-BARREL, STRUCTURAL GENOMICS, JOINT CENTER FOR KEYWDS 2 STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI- KEYWDS 3 BIOLOGY, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 01-FEB-23 3RWX 1 REMARK SEQADV LINK REVDAT 5 08-NOV-17 3RWX 1 REMARK REVDAT 4 24-DEC-14 3RWX 1 TITLE REVDAT 3 16-NOV-11 3RWX 1 TITLE REVDAT 2 20-JUL-11 3RWX 1 TITLE REVDAT 1 08-JUN-11 3RWX 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF A HYPOTHETICAL BACTERIAL OUTER MEMBRANE JRNL TITL 2 PROTEIN (BF2706) FROM BACTEROIDES FRAGILIS NCTC 9343 AT 2.40 JRNL TITL 3 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0110 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 21577 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1107 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1490 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.24 REMARK 3 BIN R VALUE (WORKING SET) : 0.3260 REMARK 3 BIN FREE R VALUE SET COUNT : 78 REMARK 3 BIN FREE R VALUE : 0.4580 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1928 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 113 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 48.03 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.09000 REMARK 3 B22 (A**2) : 1.09000 REMARK 3 B33 (A**2) : -1.63000 REMARK 3 B12 (A**2) : 0.54000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.192 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.122 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.206 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2078 ; 0.013 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 1331 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2834 ; 1.518 ; 2.039 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3329 ; 0.830 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 281 ; 5.967 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 78 ;39.691 ;27.179 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 277 ;13.986 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 2 ; 9.802 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 352 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2255 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 347 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1296 ; 0.638 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 537 ; 0.119 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2129 ; 1.316 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 782 ; 2.266 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 691 ; 3.924 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 30 A 283 REMARK 3 ORIGIN FOR THE GROUP (A): -3.7376 64.5712 18.9293 REMARK 3 T TENSOR REMARK 3 T11: 0.0714 T22: 0.0789 REMARK 3 T33: 0.0119 T12: -0.0086 REMARK 3 T13: 0.0180 T23: -0.0054 REMARK 3 L TENSOR REMARK 3 L11: 1.2861 L22: 1.6515 REMARK 3 L33: 0.2133 L12: 1.2738 REMARK 3 L13: 0.1648 L23: 0.1112 REMARK 3 S TENSOR REMARK 3 S11: -0.0482 S12: 0.0351 S13: -0.0523 REMARK 3 S21: -0.0231 S22: 0.0511 S23: -0.0077 REMARK 3 S31: 0.0500 S32: -0.0138 S33: -0.0029 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. A MET-INHIBITION PROTOCOL WAS USED REMARK 3 FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. REMARK 3 THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 2. HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS CONTAINS SUM OF TLS AND RESIDUAL U FACTORS. 3. THE REMARK 3 REFINEMENT WAS RESTRAINED AGAINST THE MAD PHASES. 4. GLYCEROL REMARK 3 (GOL) USED AS A CRYOPROTECTANT AND SULFATE (SO4) FROM THE REMARK 3 CRYSTALLIZATION WERE MODELED INTO THE STRUCTURE. 5.THE PROTEIN REMARK 3 WAS SUBJECTED TO REDUCTIVE METHYLATION PRIOR TO CRYSTALLIZATION REMARK 3 AND LYSINES HAVE BEEN MODELED AS N-DIMETHYL-LYSINE (MLY). REMARK 4 REMARK 4 3RWX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1000065478. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-MAR-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96109,0.97934,0.97908 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : VERTICAL FOCUSING MIRROR; DOUBLE REMARK 200 CRYSTAL SI(111) MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE DECEMBER 6, 2010 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21589 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 29.816 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.9100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.67200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHARP, SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 74.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.81 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M POTASSIUM SODIUM TARTRATE, 2.0M REMARK 280 AMMONIUM SULFATE, 0.1M SODIUM CITRATE PH 5.6, NANODROP, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 13.38800 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 26.77600 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 26.77600 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 13.38800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 ASN A 24 REMARK 465 ASN A 25 REMARK 465 ASP A 26 REMARK 465 ASP A 27 REMARK 465 ASP A 28 REMARK 465 GLY A 29 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MLY A 59 CE NZ CH1 CH2 REMARK 470 SER A 92 OG REMARK 470 ASP A 107 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 109 79.41 -62.13 REMARK 500 SER A 229 -44.64 -135.03 REMARK 500 ASN A 238 86.75 -156.51 REMARK 500 SER A 258 -2.45 72.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 284 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 285 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 286 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 287 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 288 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 289 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 290 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 291 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 292 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 393211 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 1. THE CONSTRUCT WAS EXPRESSED WITH AN N-TERMINAL PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 GLY 0 FOLLOWED BY RESIDUES 24-283 OF THE TARGET SEQUENCE. 2. THE REMARK 999 PROTEIN WAS REDUCTIVELY METHYLATED PRIOR TO CRYSTALLIZATION. DBREF 3RWX A 24 283 UNP Q5LBW6 Q5LBW6_BACFN 24 283 SEQADV 3RWX GLY A 0 UNP Q5LBW6 EXPRESSION TAG SEQRES 1 A 261 GLY ASN ASN ASP ASP ASP GLY THR ASN MLY ALA GLN GLU SEQRES 2 A 261 ILE ALA GLY MLY TYR GLU GLY TYR SER ILE GLY ASN CYS SEQRES 3 A 261 ALA MSE PHE THR ASP TYR VAL MSE GLY GLU MLY SER VAL SEQRES 4 A 261 ALA THR ILE VAL PRO ASN GLU ASP GLY THR ILE ASN VAL SEQRES 5 A 261 THR TYR ASP SER GLY SER GLY GLU PHE MLY LEU ASN ASN SEQRES 6 A 261 ILE MLY VAL THR SER MLY THR PHE GLU GLY SER GLY GLN SEQRES 7 A 261 VAL GLU LEU SER MSE ASN ASP MLY PRO ALA GLY ALA MLY SEQRES 8 A 261 ASP PHE THR LEU THR GLY SER ILE ASP GLU GLN GLN MLY SEQRES 9 A 261 LEU THR LEU MLY VAL ASN VAL PRO SER VAL MSE GLY GLY SEQRES 10 A 261 LEU THR ILE GLU PHE ILE GLN GLY THR LEU PRO ILE SER SEQRES 11 A 261 TYR HIS VAL SER GLY THR TYR ASN MLY GLU ALA ASN LEU SEQRES 12 A 261 SER VAL SER VAL GLY SER THR THR TYR PRO ASP ILE THR SEQRES 13 A 261 ASP CYS MLY VAL SER ILE MLY ARG SER SER ASP ASP THR SEQRES 14 A 261 VAL GLU LEU THR LEU MLY GLY LEU SER ASN LEU ASN SER SEQRES 15 A 261 SER GLN THR GLY ARG ALA MSE ASN LEU GLY ASP PHE THR SEQRES 16 A 261 VAL THR ASP VAL MLY VAL THR SER THR ASP ASN SER ILE SEQRES 17 A 261 PHE MLY ILE GLU GLY SER ILE ASN THR THR ASP THR ASN SEQRES 18 A 261 ASN THR PRO ILE THR GLY THR LEU SER GLY THR VAL SER SEQRES 19 A 261 ASN SER GLU THR ASN ILE THR PHE THR PHE MLY PRO GLY SEQRES 20 A 261 ALA MSE PRO ILE ASP ILE THR ALA MSE PHE MLY GLY MLY SEQRES 21 A 261 MLY MODRES 3RWX MLY A 32 LYS N-DIMETHYL-LYSINE MODRES 3RWX MLY A 39 LYS N-DIMETHYL-LYSINE MODRES 3RWX MSE A 50 MET SELENOMETHIONINE MODRES 3RWX MSE A 56 MET SELENOMETHIONINE MODRES 3RWX MLY A 59 LYS N-DIMETHYL-LYSINE MODRES 3RWX MLY A 84 LYS N-DIMETHYL-LYSINE MODRES 3RWX MLY A 89 LYS N-DIMETHYL-LYSINE MODRES 3RWX MLY A 93 LYS N-DIMETHYL-LYSINE MODRES 3RWX MSE A 105 MET SELENOMETHIONINE MODRES 3RWX MLY A 108 LYS N-DIMETHYL-LYSINE MODRES 3RWX MLY A 113 LYS N-DIMETHYL-LYSINE MODRES 3RWX MLY A 126 LYS N-DIMETHYL-LYSINE MODRES 3RWX MLY A 130 LYS N-DIMETHYL-LYSINE MODRES 3RWX MSE A 137 MET SELENOMETHIONINE MODRES 3RWX MLY A 161 LYS N-DIMETHYL-LYSINE MODRES 3RWX MLY A 181 LYS N-DIMETHYL-LYSINE MODRES 3RWX MLY A 185 LYS N-DIMETHYL-LYSINE MODRES 3RWX MLY A 197 LYS N-DIMETHYL-LYSINE MODRES 3RWX MSE A 211 MET SELENOMETHIONINE MODRES 3RWX MLY A 222 LYS N-DIMETHYL-LYSINE MODRES 3RWX MLY A 232 LYS N-DIMETHYL-LYSINE MODRES 3RWX MLY A 267 LYS N-DIMETHYL-LYSINE MODRES 3RWX MSE A 271 MET SELENOMETHIONINE MODRES 3RWX MSE A 278 MET SELENOMETHIONINE MODRES 3RWX MLY A 280 LYS N-DIMETHYL-LYSINE MODRES 3RWX MLY A 282 LYS N-DIMETHYL-LYSINE MODRES 3RWX MLY A 283 LYS N-DIMETHYL-LYSINE HET MLY A 32 11 HET MLY A 39 11 HET MSE A 50 8 HET MSE A 56 8 HET MLY A 59 7 HET MLY A 84 11 HET MLY A 89 19 HET MLY A 93 11 HET MSE A 105 8 HET MLY A 108 11 HET MLY A 113 11 HET MLY A 126 11 HET MLY A 130 11 HET MSE A 137 8 HET MLY A 161 11 HET MLY A 181 11 HET MLY A 185 11 HET MLY A 197 11 HET MSE A 211 13 HET MLY A 222 11 HET MLY A 232 11 HET MLY A 267 11 HET MSE A 271 8 HET MSE A 278 8 HET MLY A 280 11 HET MLY A 282 11 HET MLY A 283 12 HET SO4 A 284 5 HET SO4 A 285 5 HET GOL A 286 6 HET GOL A 287 6 HET GOL A 288 6 HET GOL A 289 6 HET GOL A 290 6 HET GOL A 291 6 HET GOL A 292 6 HETNAM MLY N-DIMETHYL-LYSINE HETNAM MSE SELENOMETHIONINE HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 MLY 20(C8 H18 N2 O2) FORMUL 1 MSE 7(C5 H11 N O2 SE) FORMUL 2 SO4 2(O4 S 2-) FORMUL 4 GOL 7(C3 H8 O3) FORMUL 11 HOH *113(H2 O) HELIX 1 1 ASN A 31 ALA A 37 1 7 HELIX 2 2 PRO A 150 VAL A 155 5 6 HELIX 3 3 GLY A 198 LEU A 202 5 5 SHEET 1 A 8 GLU A 82 ILE A 88 0 SHEET 2 A 8 ILE A 72 ASP A 77 -1 N TYR A 76 O PHE A 83 SHEET 3 A 8 TYR A 54 PRO A 66 -1 N VAL A 61 O ASP A 77 SHEET 4 A 8 GLY A 38 ASN A 47 -1 N GLY A 46 O TYR A 54 SHEET 5 A 8 LEU A 140 GLN A 146 -1 O THR A 141 N ASN A 47 SHEET 6 A 8 LEU A 127 VAL A 133 -1 N VAL A 133 O LEU A 140 SHEET 7 A 8 MLY A 113 ILE A 121 -1 N THR A 116 O ASN A 132 SHEET 8 A 8 THR A 94 VAL A 101 -1 N GLY A 97 O LEU A 117 SHEET 1 B10 GLY A 157 TYR A 159 0 SHEET 2 B10 MLY A 181 ARG A 186 -1 O ILE A 184 N GLY A 157 SHEET 3 B10 THR A 191 MLY A 197 -1 O GLU A 193 N MLY A 185 SHEET 4 B10 PHE A 216 THR A 224 -1 O VAL A 218 N LEU A 194 SHEET 5 B10 PHE A 231 THR A 240 -1 O GLU A 234 N MLY A 222 SHEET 6 B10 PRO A 246 SER A 256 -1 O GLY A 249 N ILE A 237 SHEET 7 B10 GLU A 259 PRO A 268 -1 O THR A 263 N SER A 252 SHEET 8 B10 ILE A 275 MLY A 282 -1 O ILE A 275 N PHE A 266 SHEET 9 B10 MLY A 161 VAL A 169 -1 N MLY A 161 O MLY A 282 SHEET 10 B10 THR A 172 THR A 173 -1 O THR A 172 N VAL A 169 LINK C ASN A 31 N MLY A 32 1555 1555 1.33 LINK C MLY A 32 N ALA A 33 1555 1555 1.33 LINK C GLY A 38 N MLY A 39 1555 1555 1.32 LINK C MLY A 39 N TYR A 40 1555 1555 1.32 LINK C ALA A 49 N MSE A 50 1555 1555 1.33 LINK C MSE A 50 N PHE A 51 1555 1555 1.32 LINK C VAL A 55 N MSE A 56 1555 1555 1.33 LINK C MSE A 56 N GLY A 57 1555 1555 1.33 LINK C GLU A 58 N MLY A 59 1555 1555 1.33 LINK C MLY A 59 N SER A 60 1555 1555 1.33 LINK C PHE A 83 N MLY A 84 1555 1555 1.35 LINK C MLY A 84 N LEU A 85 1555 1555 1.33 LINK C ILE A 88 N MLY A 89 1555 1555 1.33 LINK C MLY A 89 N VAL A 90 1555 1555 1.33 LINK C SER A 92 N MLY A 93 1555 1555 1.34 LINK C MLY A 93 N THR A 94 1555 1555 1.32 LINK C SER A 104 N MSE A 105 1555 1555 1.32 LINK C MSE A 105 N ASN A 106 1555 1555 1.33 LINK C ASP A 107 N MLY A 108 1555 1555 1.34 LINK C MLY A 108 N PRO A 109 1555 1555 1.36 LINK C ALA A 112 N MLY A 113 1555 1555 1.33 LINK C MLY A 113 N ASP A 114 1555 1555 1.33 LINK C GLN A 125 N MLY A 126 1555 1555 1.33 LINK C MLY A 126 N LEU A 127 1555 1555 1.32 LINK C LEU A 129 N MLY A 130 1555 1555 1.33 LINK C MLY A 130 N VAL A 131 1555 1555 1.32 LINK C VAL A 136 N MSE A 137 1555 1555 1.33 LINK C MSE A 137 N GLY A 138 1555 1555 1.32 LINK C ASN A 160 N MLY A 161 1555 1555 1.33 LINK C MLY A 161 N GLU A 162 1555 1555 1.33 LINK C CYS A 180 N MLY A 181 1555 1555 1.32 LINK C MLY A 181 N VAL A 182 1555 1555 1.32 LINK C ILE A 184 N MLY A 185 1555 1555 1.33 LINK C MLY A 185 N ARG A 186 1555 1555 1.34 LINK C LEU A 196 N MLY A 197 1555 1555 1.32 LINK C MLY A 197 N GLY A 198 1555 1555 1.34 LINK C ALA A 210 N MSE A 211 1555 1555 1.32 LINK C MSE A 211 N ASN A 212 1555 1555 1.33 LINK C VAL A 221 N MLY A 222 1555 1555 1.33 LINK C MLY A 222 N VAL A 223 1555 1555 1.34 LINK C PHE A 231 N MLY A 232 1555 1555 1.32 LINK C MLY A 232 N ILE A 233 1555 1555 1.32 LINK C PHE A 266 N MLY A 267 1555 1555 1.32 LINK C MLY A 267 N PRO A 268 1555 1555 1.33 LINK C ALA A 270 N MSE A 271 1555 1555 1.33 LINK C MSE A 271 N PRO A 272 1555 1555 1.34 LINK C ALA A 277 N MSE A 278 1555 1555 1.32 LINK C MSE A 278 N PHE A 279 1555 1555 1.32 LINK C PHE A 279 N MLY A 280 1555 1555 1.32 LINK C MLY A 280 N GLY A 281 1555 1555 1.33 LINK C GLY A 281 N MLY A 282 1555 1555 1.33 LINK C MLY A 282 N MLY A 283 1555 1555 1.33 SITE 1 AC1 5 PRO A 175 MLY A 181 MLY A 197 HOH A 322 SITE 2 AC1 5 HOH A 359 SITE 1 AC2 3 GLY A 57 GLU A 58 MLY A 59 SITE 1 AC3 5 THR A 219 SER A 236 ILE A 237 ASN A 238 SITE 2 AC3 5 HOH A 405 SITE 1 AC4 4 GLU A 162 MSE A 278 MLY A 280 HOH A 326 SITE 1 AC5 5 GLU A 58 TYR A 153 HIS A 154 MLY A 283 SITE 2 AC5 5 HOH A 392 SITE 1 AC6 4 ASP A 179 SER A 200 ASN A 201 ASP A 215 SITE 1 AC7 5 GLY A 157 THR A 158 SER A 171 ILE A 184 SITE 2 AC7 5 HOH A 360 SITE 1 AC8 2 ASN A 31 MLY A 32 SITE 1 AC9 2 THR A 254 THR A 263 CRYST1 154.154 154.154 40.164 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006487 0.003745 0.000000 0.00000 SCALE2 0.000000 0.007491 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024898 0.00000